Literature DB >> 33526572

Encephalitis in Previously Healthy Children.

Claire E Fraley1, David R Pettersson2, Dawn Nolt3.   

Abstract

Encephalitis is defined as altered mental status for more than 24 hours accompanied by 2 or more findings concerning for inflammation of the brain parenchyma: fever, seizures or other focal neurologic disorders, cerebrospinal fluid pleocytosis, and abnormal neuroimaging and electroencephalographic findings. Herpes simplex virus causes the most severe form of virus-induced encephalitis; the early administration of acyclovir can improve the prognosis of this disease. The rising interest in autoimmune causes of encephalitis, most notably anti-N-methyl-d-aspartate receptor, should prompt the clinician to consider immunomodulatory treatments, which may improve outcomes. A broad testing panel may be necessary to detect the etiologic agent; a few published pediatric cases suggest that infectious and autoimmune causes may occur concurrently in the same patient with encephalitis. More than 40% of children diagnosed as having encephalitis will not return to their previous level of neurologic function after resolution of their disease, although outcomes are highly variable depending on the etiologic agent. © American Academy of Pediatrics, 2021. All rights reserved.

Entities:  

Year:  2021        PMID: 33526572     DOI: 10.1542/pir.2018-0175

Source DB:  PubMed          Journal:  Pediatr Rev        ISSN: 0191-9601


  3 in total

Review 1.  Management of Japanese Encephalitis: A Current Update.

Authors:  Abimbola O Ajibowo; Juan Fernando Ortiz; Ammar Alli; Taras Halan; Olasunkanmi A Kolawole
Journal:  Cureus       Date:  2021-04-20

2.  Pediatric Autoimmune Encephalitis Following COVID-19 Infection.

Authors:  Mark Hilado; Michelle Banh; James Homans; Arthur Partikian
Journal:  J Child Neurol       Date:  2022-01-11       Impact factor: 2.363

3.  In-depth analysis reveals complex molecular aetiology in a cohort of idiopathic cerebral palsy.

Authors:  Na Li; Pei Zhou; Hongmei Tang; Lu He; Xiang Fang; Jinxiang Zhao; Xin Wang; Yifei Qi; Chuanbo Sun; Yunting Lin; Fengying Qin; Miaomiao Yang; Zhan Zhang; Caihua Liao; Shuxin Zheng; Xiaofang Peng; Ting Xue; Qianying Zhu; Hong Li; Yan Li; Liru Liu; Jingyu Huang; Li Liu; Changgeng Peng; Angela M Kaindl; Jozef Gecz; Dingding Han; Dong Liu; Kaishou Xu; Hao Hu
Journal:  Brain       Date:  2022-03-29       Impact factor: 13.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.